ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

Stock Information for ProPhase Labs Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ProPhase Labs Inc.

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
ProPhase Labs Announces Closing of Public Offering of Common Stock
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
ProPhase Labs Announces Proposed Public Offering of Common Stock
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry
ProPhase Labs to Present at the 2024 ThinkEquity Conference
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.